Xtrana Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Xtrana General Information

Description

Developer of nucleic acid-based tests developed so that nucleic acid-based detection systems can be utilized not only in traditional laboratory settings but also in point-of-care, point-of-service applications. The company's proprietary assays are used in drug discovery, detection of environmental and food contaminants, forensics and identity testing, human and animal diseases, genetic predisposition to disease, and other applications.

Contact Information

Website
www.xtrana.com
Formerly Known As
Biopool International, Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 590 Burbank Street
  • Suite 205
  • Broomfield, CO 80020
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Products
Acquirer
Alpha Innotech
Corporate Office
  • 590 Burbank Street
  • Suite 205
  • Broomfield, CO 80020
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xtrana Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xtrana‘s full profile, request access.

Request a free trial

Xtrana Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Xtrana Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2005505269-A Nucleic acid archive Pending 31-Aug-2001
US-6605451-B1 Contacting sample with primer pairs that target different nucleic acid sequences; diagnostic kits Inactive 06-Jun-2000
AU-6532701-A Methods and devices for multiplexing amplification reactions Pending 06-Jun-2000
US-20130143754-A1 Methods for multiplexing amplification reactions Active 06-Jun-2000
US-8815546-B2 Methods for multiplexing amplification reactions Inactive 06-Jun-2000 C12Q1/686
To view Xtrana’s complete patent history, request access »

Xtrana Acquisitions (1)

Xtrana’s most recent deal was a Reverse Merger with Alpha Innotech. The deal was made on 04-Oct-2005.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alpha Innotech 04-Oct-2005 Reverse Merger Diagnostic Equipment
To view Xtrana’s complete acquisitions history, request access »

Xtrana Exits (1)

Xtrana’s most recent exit was on 04-Oct-2005 from Alpha Innotech. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Alpha Innotech 04-Oct-2005 Completed
To view Xtrana’s complete exits history, request access »

Xtrana FAQs

  • When was Xtrana founded?

    Xtrana was founded in 1987.

  • Where is Xtrana headquartered?

    Xtrana is headquartered in Broomfield, CO.

  • What industry is Xtrana in?

    Xtrana’s primary industry is Diagnostic Equipment.

  • Is Xtrana a private or public company?

    Xtrana is a Private company.

  • What is Xtrana’s current revenue?

    The current revenue for Xtrana is .

  • When was Xtrana acquired?

    Xtrana was acquired on 04-Oct-2005.

  • Who acquired Xtrana?

    Xtrana was acquired by Alpha Innotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »